News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News Apitope aims to bounce back from MS setback Biotech looks for funding and long-term development partner
News Celgene to file potential MS blockbuster this year Success with ozanimod would justify $7.2 billion outlay for Receptos.
News Teva's CEO Vigodman steps down Firm searches for new leader, chairman takes over on interim basis.
News CDC panel votes to scrap hepatitis B birth dose advice CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
